Comparison Chart Perspective Therapeutics, Inc.

Stocks

CATX

US46489V3024

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 03:58:16 12/11/2026 HKT			5-day change	1st Jan Change
0.8700 ^USD	+10.63%		-0.30%	-68.45%

11-10	Wedbush Adjusts Price Target on Perspective Therapeutics to $7 From $9, Maintains Outperform Rating	MT
11-10	Perspective Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	PERSPECTIVE THERAPEUTICS, INC.	Other Biotechnology & Medical Research	+10.33%	-0.30%	-68.45%	-60.92%	-85.31%	94.96M